Document:

Second Amended and Restated Executive Severence Agreement

 Exhibit 10.11 
 SECOND AMENDED AND RESTATED 
 EXECUTIVE VICE PRESIDENT SEVERANCE
AGREEMENT 
 This Second Amended and Restated Executive Severance Agreement (this “Agreement”)
is made as of this 16th day of May, 2011, between Apria Healthcare Group Inc., a Delaware corporation (the “Company”), and Harriet Albery (the “Executive”). 

RECITALS 

A. It is the desire of the Company to retain the services of the Executive and to recognize the Executive’s contribution to the
Company. 
 B. The Company and the Executive wish to set forth certain terms and conditions of the Executive’s employment.

 C. The Company wishes to provide to the Executive certain benefits in the event that her employment is terminated by the
Company without Cause (as defined below) or in the event that she terminates her employment for Good Reason (as defined below), in order to encourage the Executive’s performance and continued commitment to the Company. 

NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements set forth below, the parties hereto
agree as follows: 
 1. Positions and Duties. During the period of her employment with the Company (the “Period of
Employment”), the Executive shall serve as the Company’s Executive Vice President, Sales, or in such other position and shall undertake such duties and have such authority as the Company, through its Chief Executive Officer or his
designee, the Chief Operating Officer, shall assign to the Executive from time to time in the Company’s sole and absolute discretion. The Company has the right to change the nature, amount or level of authority and responsibility assigned to
the Executive at any time, for any reason or no reason, and with or without cause. The Company may also change the title or titles assigned to the Executive at any time, for any reason or no reason, and with or without cause. The Executive agrees to
devote substantially all of her working time and efforts to the business and affairs of the Company. The Executive further agrees that she shall not undertake any outside activities which create a conflict of interest with her duties to the Company,
or which, in the judgment of the Chief Executive Officer of the Company or his designee, interfere with the performance of the Executive’s duties to the Company. 
 2. Compensation and Benefits. During the Period of Employment, the Executive shall be entitled to the compensation and benefits set forth in this Section 2. 

(a) Salary. The Executive’s salary shall be such salary as the Company assigns to her from time to time in
accordance with its regular practices and policies. The parties to this Agreement recognize that the Company may, in its sole discretion, change such salary on a prospective basis at any time. 

  
 1 

 (b) Bonus. The Executive shall be entitled to participate in the
Company’s Executive Bonus Plan or such other bonus plans applicable to her position as may be in effect from time to time. The parties to this Agreement recognize that such bonus plans may be amended and/or terminated by the Company at any time
without the consent of the Executive in accordance with the terms of such bonus plans. 
 (c) Expenses.
The Executive shall be entitled to receive reimbursement for all reasonable and customary expenses incurred by the Executive in performing services for the Company in accordance with the Company’s reimbursement policies as they may be in effect
from time to time. The parties to this Agreement recognize that such policies may be amended and/or terminated by the Company at any time without the consent of the Executive. Any reimbursement made to the Executive pursuant to this
Section 2(c) shall be made as soon as reasonably practicable but in all events not later than the end of the calendar year following the year in which the related expense was incurred. 

(d) Other Benefits. The Executive shall be entitled to participate in all employee benefit plans, programs and
arrangements of the Company (including, without limitation, equity grants and insurance, retirement and vacation plans, the deferred compensation plan and any other programs and arrangements), in accordance with the terms of such plans, programs or
arrangements as they shall be in effect from time to time; provided, however, that nothing herein shall entitle the Executive to any specific awards under the Company’s equity compensation plans or other discretionary employee benefit plans.
The parties to this Agreement recognize that the Company may terminate or modify such plans, programs or arrangements at any time without the consent of the Executive. 
 3. Grounds for Termination. The Executive’s employment may be terminated by the Company or the Executive at any time, for any reason or no reason, with or without Cause or Good Reason (as such
terms are defined below), and except as expressly provided herein, with or without any advance notice. The Executive’s employment may end for any one of the following reasons: 

(a) Without Cause or Good Reason. The Executive or the Company may terminate the Executive’s employment at any
time, without Cause (in the case of the Company) or for Good Reason (in the case of the Executive), by giving the other party to this Agreement at least thirty (30) days advance written notice of such termination. 

(b) Death. The Executive’s employment hereunder shall terminate upon her death. 

(c) Disability. If, as a result of the Executive’s incapacity due to physical or mental illness, the Executive
shall have been unable to perform the essential functions of her position, even with reasonable accommodation that does not impose an undue hardship on the Company, on a full-time basis for the entire period of six (6) consecutive months, and
within thirty (30) days after written notice of termination is given (which may occur before or after the end of such six-month period), shall not have returned to the performance of her duties hereunder on a full-time basis (a
“disability”), the Company may terminate the Executive’s employment on account of such disability. 

  
 2 

 (d) Cause. The Company may terminate the Executive’s employment
hereunder for Cause. For purposes of this Agreement, “Cause” shall mean that the Company, acting in good faith based upon the information then known to the Company, determines that the Executive has (i) engaged in or committed willful
misconduct; (ii) engaged in or committed theft, fraud or other illegal conduct; (iii) refused or demonstrated an unwillingness to substantially perform her duties after written demand for substantial performance is delivered by the Company
that specifically identifies the manner in which the Company believes the Executive has not substantially performed her duties; (iv) refused or demonstrated an unwillingness to reasonably cooperate in good faith with any Company or government
investigation or provide testimony therein (other than such failure resulting from the Executive’s disability); (v) engaged in or committed insubordination; (vi) engaged in or committed any willful act that is likely to and which does
in fact have the effect of injuring the reputation or business of the Company; (vii) violated any fiduciary duty; (viii) violated Executive’s duty of loyalty to the Company; (ix) violated the Company’s Code of Ethical
Business Conduct; (x) used alcohol or drugs (other than drugs prescribed to the Executive by a physician and used by the Executive for their intended purpose for which they had been prescribed) in a manner which materially and repeatedly
interferes with the performance of her duties hereunder or which has the effect of materially injuring the reputation or business of the Company; or (xi) engaged in or committed a breach of any term of this Agreement. For purposes of the above
clauses (i) and (vi) of this Section 3(d), no act, or failure to act, on the Executive’s part shall be considered willful unless done or omitted to be done, by her without reasonable belief that her action or omission was in the
best interest of the Company. Notwithstanding the foregoing, the Executive shall not be deemed to have been terminated for Cause without delivery to the Executive of a notice of termination signed by the Company’s Chief Executive Officer
stating that, in the good faith opinion of the officer signing such notice, the Executive has engaged in or committed conduct of the nature described above in the second sentence of this Section 3(d), and specifying the particulars thereof.

 4. Payments upon Termination. 
 (a) Without Cause or with Good Reason. In the event that the Executive’s employment is terminated by the Company for any reason other than death, disability or Cause as defined in
Sections 3(b), (c) and (d) of this Agreement, or in the event that the Executive terminates her employment hereunder with Good Reason as defined in Section 4(c) of this Agreement, the Executive shall be entitled to receive
severance pay in an aggregate amount equal to 100% of her Annual Compensation, which shall be paid, subject to Section 11(b), in periodic installments in accordance with the Company’s customary payroll practices over a period of one
(1) year, less any amounts required to be withheld by applicable law, with the first such installment payable in the month following the month in which the Executive’s Separation from Service (as such term is defined in Section 4(f))
occurs; provided, however, that any such payment shall be contingent upon the Executive’s execution and delivery to the Company of a valid release of all claims the Executive may have against the Company in a form acceptable to the Company and
continued compliance with the restrictive covenants described in Sections 7-9 below; and provided, further, that, if the Executive provides such release of claims, in no event shall the Executive be entitled to payment pursuant to this
Section 4(a) of less than $5,000, which amount the parties agree is good and adequate consideration, in and of itself, for such 

  
 3 

 
release. The Company will also pay to the Executive any Accrued Obligations (as defined in Section 4(e) below). 
 Annual Compensation. For purposes of this Section 4, the term “Annual Compensation” means an amount equal to the Executive’s annual base salary at the rate in effect on the date
on which the Executive received or gave written notice of her termination, plus the sum of (i) an amount equal to the average of the annual bonuses with respect to the Company’s two (2) most recently completed fiscal years, if any,
determined to be payable and/or paid to the Executive under the Company’s Executive Bonus Plan (or comparable bonus plan) prior to such notice of termination, and (ii) an amount determined by the Company from time to time in its sole
discretion to be equal to the annual cost of providing the Executive with a continuation of her medical, dental and vision insurance under COBRA. 
 (b) Good Reason. For purposes of this Section 4 the term “Good Reason” means the occurrence of any of the following, without the written consent of the Executive: 

 

	 	(i)	any material reduction in the Executive’s annual base salary; provided that, for this purpose, in no event shall a general one-time “across-the-board”
salary reduction not exceeding ten percent (10%) which is imposed simultaneously on all executive officers of the Company be considered a “material reduction”; 

 

	 	(ii)	any requirement by the Company that the Executive relocate her residence to be based at an office location which will result in an increase of more than thirty
(30) miles in the Executive’s one-way commute (which the parties agree constitutes a “material” relocation); or 

  

	 	(iii)	failure of the Company to require a successor to expressly assume and perform this Agreement in accordance with Section 5(a) below. 

provided, however, that any such condition or conditions, as applicable, shall not constitute grounds for “Good Reason” unless
both (x) the Executive provides written notice to the Company of the condition claimed to constitute grounds for Good Reason within sixty (60) days of the initial existence of such condition(s), and (y) the Company fails to remedy
such condition(s) within thirty (30) days of receiving such written notice thereof; and provided, further, that in all events the termination of the Executive’s employment with the Company shall not constitute a termination
for “Good Reason” unless such termination occurs not more than one hundred and twenty (120) days following the initial existence of the condition claimed to constitute grounds for such a “Good Reason.” 

(c) Release of all Claims. The Executive understands and agrees that the Company’s obligation to pay the
Executive severance pay under this Agreement is subject to the Executive’s execution and delivery to the Company of a valid written waiver and release of all claims which the Executive may have against the Company and/or its successors in a
form acceptable to the Company in its sole and absolute discretion. 

  
 4 

 (d) No Mitigation or Offset. Notwithstanding anything herein to the
contrary, the amount of any payment or benefit provided for in this Section 4 shall not be reduced, offset or subject to recovery by the Company or any of its subsidiaries or affiliates by reason of any compensation earned by the Executive as
the result of employment by another employer after the Executive’s employment with the Company terminates for any reason, unless such employment violates the restrictions of Section 7 of this Agreement. In addition, the Executive shall be
under no obligation to seek other employment or to take any other actions to mitigate the amounts payable under this Section 4. 
 (e) Termination Due To Death, Disability or Cause; Termination by Executive Other Than for Good Reason. In the event that the Executive’s employment is terminated due to her death or
disability, by the Company for Cause or by the Executive other than for Good Reason, the Company shall not be obligated to pay the Executive any amount other than reimbursement for business expenses incurred prior to her termination and in
compliance with the Company’s reimbursement policies, any unpaid salary for days worked prior to the termination, all other amounts accrued or earned by the Executive through the date of termination under the then existing plans and policies of
the Company, and any amounts owing in respect of the Company’s indemnification obligations to the Executive (collectively, the “Accrued Obligations”). 

(f) Separation from Service. As used herein, a “Separation from Service” occurs when the Executive dies,
retires, or otherwise has a termination of employment with the Company that constitutes a “separation from service” within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative
definitions available thereunder. 
 5. Successors; Binding Agreement. 

(a) The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise)
to all or substantially all of the business and/or assets of the Company, to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had
taken place. Failure of the Company to obtain such assumption and agreement prior to the effectiveness of any such succession shall be a breach of this Agreement and shall entitle the Executive to compensation from the Company in the same amount and
on the same terms as she would be entitled to hereunder if she terminated her employment for Good Reason, except that for purposes of implementing the foregoing, the date on which any such succession becomes effective shall be deemed the date of
termination. As used in this Agreement, “Company” shall mean the Company as herein before defined and any successor to its business and/or assets as aforesaid which executes and delivers the agreement provided for in this Section 5 or
which otherwise becomes bound by all the terms and provisions of this Agreement by operation of law. 
 (b) This
Agreement and all rights of the Executive hereunder shall inure to the benefit of and be enforceable by the Executive’s personal or legal representatives, executors, administrator, successors, heirs, distributees, devisees and legatees. If the
Executive should die while any amounts would still be payable to her hereunder if she had continued to live, all such 

  
 5 

 
amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to the Executive’s devisee, legatee, or other designee or, if there be no such
designee, to the Executive’s estate. 
 6. Notices. For the purposes of this Agreement, notices, demands and all
other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given when delivered personally, by facsimile, email or other form of written electronic transmission, by overnight courier or by
registered or certified mail, postage prepaid, or mailed by United States certified or registered mail, return receipt requested, postage prepaid, addressed as follows: 
 If to the Executive: 
 Harriet Albery 

3125 S. Hills Court 
 Denver, Colorado 80210 
 If to the Company: 

Apria Healthcare Group Inc. 
 26220 Enterprise Court 
 Lake Forest, California 92630 

Attention: Executive Vice President, Human Resources 
 or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt. 

7. Antisolicitation; Noncompetition. 
 (a) The Executive promises and agrees that, during the period of her employment by the Company and for a period of one year thereafter, she will not influence or attempt to influence customers or patients
of the Company or any of its present or future subsidiaries or affiliates, either directly or indirectly, to divert their business to any individual, partnership, firm, corporation or other entity then in competition with the business of the
Company, or any subsidiary or affiliate of the Company, where the identity of the customer or patient, or any information concerning the relationship between the customer or patient and the Company, is a trade secret or other Confidential Material
(as defined below). 
 (b) In order avoid the disclosure by the Executive of the Company’s trade secrets or
other Confidential Material, the Executive promises and agrees that, during the period of her employment by the Company and for a period of one year thereafter, she will not enter business or work with or for, whether as an employee, consultant or
otherwise, any of the following corporations or their respective subsidiaries or affiliates: Lincare Holdings, Inc.; Rotech Healthcare, Inc.; American HomePatient, Inc.; Walgreens Home Care; Medco Health Solutions Inc.; Aerocare; Preferred Homecare;
CVS Caremark; Express Scripts; Crescent Healthcare; Braden Partners, dba Pacific Pulmonary Services; BioScrip, Inc.; The MedGroup; and Van G. Miller Associates, dba VGM. 

  
 6 

 (c) The Executive expressly acknowledges and agrees that if the Company has
a reasonable good faith belief that she is in violation of any of the restrictive covenants set forth in this Section 7, then the Company, following written notice to the Executive explaining the basis for its belief, may suspend any future
payments scheduled to be made pursuant to Section 4, unless and until the Executive establishes to the Company’s reasonable good faith satisfaction that no such violation has occurred. 

8. Soliciting Employees. The Executive promises and agrees that, for a period of one year following termination of her employment,
she will not, directly or indirectly, solicit any of the Company employees who earned annually $50,000 or more as a Company employee during the last six months of her own employment to work for any other business, individual, partnership, firm,
corporation, or other entity. 
 9. Confidential Information. 

(a) The Executive, in the performance of her duties on behalf of the Company, shall have access to, receive and be
entrusted with confidential information, including but not limited to systems technology, field operations, reimbursement, development, marketing, organizational, financial, management, administrative, clinical, customer, distribution and sales
information, data, specifications and processes presently owned or at any time in the future developed, by the Company or its agents or consultants, or used presently or at any time in the future in the course of its business that is not otherwise
part of the public domain (collectively, the “Confidential Material”). All such Confidential Material is considered secret and will be available to the Executive in confidence. Except in the performance of duties on behalf of the Company,
the Executive shall not, directly or indirectly for any reason whatsoever, disclose or use any such Confidential Material, unless such Confidential Material ceases (through no fault of the Executive’s) to be confidential because it has become
part of the public domain. All records, files, drawings, documents, notes, disks, diskettes, tapes, magnetic media, photographs, equipment and other tangible items, wherever located, relating in any way to the Confidential Material or otherwise to
the Company’s business, which the Executive prepares, uses or encounters during the course of her employment, shall be and remain the Company’s sole and exclusive property and shall be included in the Confidential Material. Upon
termination of this Agreement by any means, or whenever requested by the Company, the Executive shall promptly deliver to the Company any and all of the Confidential Material, not previously delivered to the Company, that may be or at any previous
time has been in the Executive’s possession or under the Executive’s control. 
 (b) The Executive
hereby acknowledges that the sale or unauthorized use or disclosure of any of the Company’s Confidential Material by any means whatsoever and at any time before, during or after the Executive’s employment with the Company shall constitute
unfair competition. The Executive agrees she shall not engage in unfair competition either during the time employed by the Company or any time thereafter. 
 10. Parachute Limitation. Notwithstanding any other provision of this Agreement, the Executive shall not have any right to receive any payment or other benefit under this Agreement, any other
agreement, or any benefit plan if such right, payment or benefit, taking into account all other rights, payments or benefits to or for the Executive under this Agreement, 

  
 7 

 
all other agreements, and all benefit plans, would cause any right, payment or benefit to the Executive under this Agreement to be considered a “parachute payment” within the meaning of
Section 280G(b)(2) of the Internal Revenue Code as then in effect (a “Parachute Payment”). In the event that the receipt of any such right or any other payment or benefit under this Agreement, any other agreement, or any benefit plan
would cause the Executive to be considered to have received a Parachute Payment under this Agreement, then the Executive shall have the right, in the Executive’s sole discretion, to designate those rights, payments or benefits under this
Agreement, any other agreements, and/or any benefit plans, that should be reduced or eliminated so as to avoid having the right, payment or benefit to the Executive under this Agreement be deemed to be a Parachute Payment. 

11. Section 409A. 
 (a) It is intended that any amounts payable under this Agreement and the Company’s and the Executive’s exercise of authority or discretion hereunder shall comply with Section 409A of the
Code (including the Treasury regulations and other published guidance relating thereto) (“Section 409A”) so as not to subject the Executive to payment of any interest or additional tax imposed under Section 409A. To the
extent that any amount payable under this Agreement would trigger the additional tax imposed by Section 409A, the Agreement shall be construed and interpreted in a manner to avoid such additional tax yet preserve (to the nearest extent
reasonably possible) the intended benefit payable to the Executive. 
 (b) Notwithstanding any provision of this
Agreement to the contrary, if the Executive is a “specified employee” within the meaning of Treasury Regulation Section 1.409A-1(i) as of the date of the Executive’s Separation from Service, the Executive shall not be entitled to
any payment or benefit pursuant to Section 4(a) until the earlier of (i) the date which is six (6) months after the Executive’s Separation from Service for any reason other than death, or (ii) the date of the
Executive’s death. Any amounts otherwise payable to the Executive upon or in the six (6) month period following the Executive’s Separation from Service that are not so paid by reason of this Section 11(b) shall be paid as soon as
practicable (and in all events within thirty (30) days) after the date that is six (6) months after the Executive’s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty (30) days, after
the date of the Executive’s death), and any such payments shall be increased by an amount equal to interest on such payments for the period commencing with the date such payment would have otherwise been made but for this Section 11(b)
(the “Original Payment Date”) and ending on the date such payment is actually made, at an interest rate equal to the prime rate in effect as of the Original Payment Date plus one point (for this purpose, the prime rate will be based on the
rate published from time to time in The Wall Street Journal). The provisions of this Section 11(b) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty or interest pursuant to Section 409A of the
Code. 
 12. Modification and Waiver. No provisions of this Agreement may be modified, waived or discharged unless such
waiver, modification or discharge is agreed to in writing signed by the Executive and the Chief Executive Officer of the Company. No waiver by either party hereto at any time of any breach by the other party hereto of, or compliance with, any
condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent

  
 8 

 
time. No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not set forth expressly in this
Agreement. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of California without regard to its conflicts of law principles. 

13. Severability. The provisions of this Agreement are severable and in the event that a court of competent jurisdiction
determines that any provision of this Agreement is in violation of any law or public policy, in whole or in part, only the portions of this Agreement that violate such law or public policy shall be stricken. All portions of this Agreement that do
not violate any statute or public policy shall not be affected thereby and shall continue in full force and effect. Further, any court order striking any portion of this Agreement shall modify the stricken terms as narrowly as possible to give as
much effect as possible to the intentions of the parties under this Agreement. 
 14. Counterparts. This Agreement may be
executed in one or more counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument. 
 15. Arbitration. Any dispute or controversy arising under or in connection with this Agreement or the Executive’s employment by the Company shall be settled exclusively by arbitration,
conducted before a single neutral arbitrator in accordance with the American Arbitration Association’s National Rules for Resolution of Employment Disputes as then in effect. Judgment may be entered on the arbitrator’s award in any court
having jurisdiction; provided, however, that the Company shall be entitled to seek a restraining order or injunction in any court of competent jurisdiction to prevent any continuation of any violation of the provisions of Sections 7, 8 or 9 of this
Agreement and the Executive hereby consents that such restraining order or injunction may be granted without the necessity of the Company’s posting any bond, and provided, further, that the Executive shall be entitled to seek specific
performance of her right to be paid until the date of employment termination during the pendency of any dispute or controversy arising under or in connection with this Agreement. Each party shall pay its own attorneys’ fees and costs. If any
party prevails on a statutory claim which affords attorneys’ fees and costs, the arbitrator may award reasonable attorneys’ fees and/or costs to the prevailing party. The fees and expenses of the arbitrator and the arbitration shall be
borne by the Company. 
 16. Entire Agreement. This Agreement sets forth the entire agreement of the parties hereto in
respect of the subject matter contained herein and supersedes all prior agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or representative of any party
hereto; and any prior agreement of the parties hereto in respect of the subject matter contained herein is hereby terminated and canceled. 
 [signature page follows] 

  
 9 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year first
above written. 
  

			
	APRIA HEALTHCARE GROUP INC.
		
	By:	 	/s/ Howard Derman
		 	Name: Howard Derman
		 	Title: Executive Vice President, Human Resources

  

			
	EXECUTIVE
		
	By:	 	/s/ Harriet Albery
		 	Name: Harriet Albery

  
 S-1Supplement No. 2 to the Notes Security Agreement

 Exhibit 10.25 
 Execution Version 
 SECURITY AGREEMENT SUPPLEMENT 

SUPPLEMENT NO. 2, dated as of August 8, 2011, to the Security Agreement (as amended, restated, supplemented or otherwise modified, the
“Security Agreement”), dated as of October 28, 2008, by and among Sky Merger Sub Corporation and Apria Healthcare Group Inc., a Delaware corporation and successor in interest to Sky Merger Sub Corporation, Holdings, the other
Grantors party thereto and Bank of America, N.A. (“BofA”) as the initial collateral agent for the Secured Parties. 
 A. On August 13, 2009, U.S. Bank National Association succeeded BofA as the collateral agent (the “Collateral Agent”) for the Secured Parties pursuant to Section 6.11 of the
Intercreditor and Collateral Agency Agreement, dated as of May 27, 2009. 
 B. Capitalized terms used herein and not
otherwise defined herein shall have the meanings assigned to such terms in the Security Agreement. 
 C. Section 8.14 of
the Security Agreement provides that additional Restricted Subsidiaries of the Grantors may become Grantors under the Security Agreement by execution and delivery of an instrument substantially in the form of this Supplement. The undersigned
Restricted Subsidiaries (each, a “New Subsidiary”) is executing this Supplement in accordance with the requirements of the Security Agreement to become a Subsidiary Party under the Security Agreement. 

Accordingly, the Collateral Agent and each New Subsidiary agree as follows: 

Section 1. In accordance with Section 8.14 of the Security Agreement, each New Subsidiary by its signature below becomes a
Grantor under the Security Agreement with the same force and effect as if originally named therein as a Grantor and each New Subsidiary hereby (a) agrees to all the terms and provisions of the Security Agreement applicable to it as a Grantor
thereunder and (b) represents and warrants that the representations and warranties made by it as a Grantor thereunder are true and correct on and as of the date hereof; provided that, to the extent that such representations and
warranties specifically refer to an earlier date, they shall be true and correct in all respects as of such earlier date and provided further that references to Schedule II of the Security Agreement shall be deemed to refer to the “Equity
Interests” section of Schedule I hereto with respect to each of the New Subsidiaries. In furtherance of the foregoing, each New Subsidiary, as security for the payment and performance in full of the Secured Obligations does hereby create and
grant to the Collateral Agent, its successors and assigns, for the benefit of the Secured Parties, their successors and assigns, a security interest in and lien on all of such New Subsidiary’s right, title and interest in and to the Collateral
(as defined in the Security Agreement) of such New Subsidiary. Each reference to a “Grantor” in the Security Agreement shall be deemed to include each New Subsidiary. The Security Agreement is hereby incorporated herein by reference.

 Section 2. Each New Subsidiary represents and warrants to the Collateral Agent and the other Secured Parties that this
Supplement has been duly authorized, executed 

 
and delivered by it and constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms. 

Section 3. This Supplement may be executed in counterparts (and by different parties hereto on different counterparts), each of
which shall constitute an original, but all of which when taken together shall constitute a single contract. This Supplement shall become effective when the Collateral Agent shall have received a counterpart of this Supplement that bears the
signature of each New Subsidiary and the Collateral Agent has executed a counterpart hereof. Delivery of an executed signature page to this Supplement by facsimile transmission shall be as effective as delivery of a manually signed counterpart of
this Supplement. 
 Section 4. Each New Subsidiary hereby represents and warrants that (a) set forth on Schedule
I attached hereto is a true and correct schedule of the location of any and all Collateral of such New Subsidiary and (b) set forth under its signature hereto is the true and correct legal name of each New Subsidiary, its jurisdiction of
formation and the location of its chief executive office (or if different, its “location” as determined in accordance with Section 9-307 of the Uniform Commercial Code). 

Section 5. Except as expressly supplemented hereby, the Security Agreement shall remain in full force and effect. 

Section 6. THIS SUPPLEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 

Section 7. In case any one or more of the provisions contained in this Supplement should be held invalid, illegal or unenforceable
in any respect, the validity, legality and enforceability of the remaining provisions contained herein and in the Security Agreement shall not in any way be affected or impaired thereby (it being understood that the invalidity of a particular
provision in a particular jurisdiction shall not in and of itself affect the validity of such provision in any other jurisdiction). The parties hereto shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable
provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions. 
 Section 8. All communications and notices hereunder shall be in writing and given as provided in Section 8.01 of the Security Agreement. 

Section 9. Each New Subsidiary agrees to reimburse the Collateral Agent for its reasonable out-of-pocket expenses in connection with
this Supplement, including all Attorney Costs of counsel for the Collateral Agent. 

 IN WITNESS WHEREOF, each New Subsidiary and the Collateral Agent have duly executed this
Supplement to the Security Agreement as of the date first above written. 
  

			
	301 CITY AVENUE, LLC
		
	By:	 	 /s/ Robert S. Holcombe

		 	Name: Robert S. Holcombe
		 	Title: Executive Vice President
	
	Legal Name: 301 CITY AVENUE, LLC
		 	Jurisdiction of Formation: West Virginia
		 	 Location of Chief Executive Office: 26220
 Enterprise Court, Lake Forest, CA 92630

 [Security Supplement Agreement No. 2] 

 IN WITNESS WHEREOF, each New Subsidiary and the Collateral Agent have duly executed this
Supplement to the Security Agreement as of the date first above written. 
  

			
	301 MANAGEMENT, INC.
		
	 By:
	 	 /s/ Robert S. Holcombe

		 	Name: Robert S. Holcombe
		 	Title: Executive Vice President
	
	Legal Name: 301 MANAGEMENT, INC.
		 	Jurisdiction of Formation: Delaware
		 	Location of Chief Executive Office: 26220 Enterprise Court, Lake Forest, CA 92630
	
	VALESCENT HEALTH LLC
		
	By:	 	 /s/ Raoul Smyth

		 	Name: Raoul Smyth
		 	Title: Vice President
	
	Legal Name: VALESCENT HEALTH LLC
		 	Jurisdiction of Formation: Delaware
		 	Location of Chief Executive Office: 26220 Enterprise Court, Lake Forest, CA 92630

 [Security Supplement Agreement No. 2] 

			
	 U.S. Bank National Association, as Collateral Agent

		
	    By:	 	 /s/ Raymond S. Haverstock

		 	Name: Raymond S. Haverstock
		 	Title: Vice President

 [Security Supplement Agreement No. 2] 

					
	SCHEDULE I TO SECURITY AGREEMENT SUPPLEMENT
	
	LOCATION OF COLLATERAL
			
		  	301 CITY AVENUE, LLC	  	
			
	Description	  		  	Location
			
		  	None.	  	
			
		  	301 MANAGEMENT, INC.	  	
			
	Description	  		  	 Location

			
		  	None.	  	
			
		  		  	
			
		  	VALESCENT HEALTH LLC	  	
			
	Description	  		  	 Location

			
		  		  	
			
		  	None.	  	

 EQUITY INTERESTS 
  

											
	301 CITY AVENUE, LLC	  
	Issuer	  	 Number of
 Certificate
	  	 Registered
 Owner
	  	 Number and
 Class of
 Equity Interest
	  	 Percentage
 of Equity Interests
	 
	 301 CITY AVENUE, LLC
	  	Not Certificated	  	301 Management, Inc.	  	N/A	  	 	100%	  
	
	 301 MANAGEMENT, INC.
  
	   
 

	Issuer	  	 Number of
 Certificate
	  	 Registered
 Owner
	  	 Number and
 Class of
 Equity Interest
	  	 Percentage
 of Equity Interests
	 
	 301 MANAGEMENT, INC.
	  	1	  	Apria Healthcare, Inc.	  	100 shares	  	 	100%	  
	
	 VALESCENT HEALTH LLC
  
	   
 

	Issuer	  	 Number of
 Certificate
	  	 Registered
 Owner
	  	 Number and
 Class of
 Equity Interest
	  	 Percentage
 of Equity Interests
	 
	 VALESCENT HEALTH LLC
	  	Not Certificated	  	Apria Healthcare Group Inc.	  	N/A	  	 	100%	  

 PROMISSORY NOTES 

							
	 301 CITY AVENUE, LLC
  

	Issuer	  	 Principal
 Amount as of the date of
 issuance (or delivery)
	  	Date of Note/Instrument	  	Maturity Date
	
	 None.

 

	 301 MANAGEMENT, INC.
  

	Issuer	  	 Principal
 Amount as of the date of
 issuance (or delivery)
	  	Date of Note/Instrument	  	Maturity Date
	
	None.
	
	 VALESCENT HEALTH LLC
  

	Issuer	  	 Principal
 Amount as of the date of
 issuance (or delivery)
	  	Date of Note/Instrument	  	Maturity Date

 None. 
 COMMERCIAL TORT CLAIMS 
 301 CITY AVENUE, LLC 

None. 
 301
MANAGEMENT, INC. 
 None. 
 VALESCENT HEALTH LLC 

 None. 
 INTELLECTUAL PROPERTY 
 301 CITY AVENUE, LLC 

((a) U.S. Patents, U.S. Patent Applications, (b) U.S. Trademark Registrations and Applications, (c) U.S. Copyright Registrations and
Applications, (d) Domain Names, (e) exclusive Licenses of U.S. Patents, Patent Applications, Trademark Registrations or Applications and Copyrights where such New Subsidiary is the Licensee) 

None. 
 301
MANAGEMENT, INC. 
 ((a) U.S. Patents, U.S. Patent Applications, (b) U.S. Trademark Registrations and Applications, (c) U.S. Copyright
Registrations and Applications, (d) Domain Names, (e) exclusive Licenses of U.S. Patents, Patent Applications, Trademark Registrations or Applications and Copyrights where such New Subsidiary is the Licensee) 

None. 
 VALESCENT
HEALTH LLC 
 ((a) U.S. Patents, U.S. Patent Applications, (b) U.S. Trademark Registrations and Applications, (c) U.S. Copyright
Registrations and Applications, (d) Domain Names, (e) exclusive Licenses of U.S. Patents, Patent Applications, Trademark Registrations or Applications and Copyrights where such New Subsidiary is the Licensee) 

None. 
 REAL
PROPERTY (LEASED AND OWNED) 
 301 CITY AVENUE, LLC 
 None. 

 301 MANAGEMENT, INC. 
 None 
 VALESCENT HEALTH LLC 

None 
 BANK
ACCOUNTS 
 301 CITY AVENUE, LLC 
 None. 
 301 MANAGEMENT, INC. 

None. 
 VALESCENT
HEALTH LLC 
 None.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}]]